Abstract
To the Editor.— I believe that a protest must be made regarding the position and actions taken by the Food and Drug Administration (FDA) in relationship to the use of methyl methacrylate. I think there is justification for the FDA to evaluate new and experimental drugs and to control these drugs in relationship to the toxicity and possible harm that may be done to the body by their use, and thus control the use of toxic elements on the population before adequate study has been completed. But, for the life of me, I cannot understand the logic of the position taken by these federal agencies in the use of this drug, restricting its use according to their present attitudes. Under what logic can this ruling be explained, that methyl methacrylate does not harm the human body when it is used about the hip joint and about the knee joint, but
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
